Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene - PubMed (original) (raw)

. 2003 Apr 15;63(8):1743-7.

Affiliations

PMID: 12702554

Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene

Charlotta Lindvall et al. Cancer Res. 2003.

Abstract

Reconstitution of telomerase activity by ectopic expression of telomerase reverse transcriptase (hTERT) results in an immortal phenotype in various types of normal human cells, including fibroblasts. Despite lack of transformation characteristics, it is unclear whether hTERT-immortalized cells are physiologically and biochemically the same as their normal counterparts. Here, we compared the gene expression profiles of normal and hTERT-immortalized fibroblasts by using a cDNA microarray containing 20,736 cDNA clones and identified 172 dysregulated genes or expressed sequence tags (ESTs). One of the highly expressed genes in the hTERT-immortalized fibroblasts (hTERT-BJ cells) encodes epiregulin, a potent growth factor. Blockade of epiregulin reduced the growth of hTERT-BJ cells and colony formation of hTERT-transformed fibroblasts. Moreover, inhibition of epiregulin function in immortal hTERT-BJ cells triggered a senescence program. Our results suggest that both activation of telomerase and subsequent induction of epiregulin are required for sustained cell proliferation. Given the significant difference in gene expression profiles between normal and hTERT-immortalized fibroblasts and the close relationship between epiregulin and tumorigenesis, we conclude that hTERT-immortalized cells may not replace their normal counterparts for studies of normal cell biology and that the use of hTERT for expansion of normal human cells for therapeutic purposes must be approached with caution.

PubMed Disclaimer

Cited by

Cholesteatoma fibroblasts promote epithelial cell proliferation through overexpression of epiregulin.
Yoshikawa M, Kojima H, Yaguchi Y, Okada N, Saito H, Moriyama H. Yoshikawa M, et al. PLoS One. 2013 Jun 24;8(6):e66725. doi: 10.1371/journal.pone.0066725. Print 2013. PLoS One. 2013. PMID: 23826119 Free PMC article.
Normal human fibroblasts are resistant to RAS-induced senescence.
Benanti JA, Galloway DA. Benanti JA, et al. Mol Cell Biol. 2004 Apr;24(7):2842-52. doi: 10.1128/MCB.24.7.2842-2852.2004. Mol Cell Biol. 2004. PMID: 15024073 Free PMC article.
Epiregulin as a therapeutic target in non-small-cell lung cancer.
Sunaga N, Kaira K. Sunaga N, et al. Lung Cancer (Auckl). 2015 Oct 12;6:91-98. doi: 10.2147/LCTT.S60427. eCollection 2015. Lung Cancer (Auckl). 2015. PMID: 28210154 Free PMC article. Review.
3-Nitrobenzanthrone promotes malignant transformation in human lung epithelial cells through the epiregulin-signaling pathway.
Chen KY, Tseng CH, Feng PH, Sun WL, Ho SC, Lin CW, Van Hiep N, Luo CS, Tseng YH, Chen TT, Liu WT, Lee KY, Wu SM. Chen KY, et al. Cell Biol Toxicol. 2022 Oct;38(5):865-887. doi: 10.1007/s10565-021-09612-1. Epub 2021 May 25. Cell Biol Toxicol. 2022. PMID: 34036453
The effect of epiregulin on epidermal growth factor receptor expression and proliferation of oral squamous cell carcinoma cell lines.
Kong DC, Chew KY, Tan EL, Khoo SP. Kong DC, et al. Cancer Cell Int. 2014 Nov 18;14:65. doi: 10.1186/1475-2867-14-65. eCollection 2014. Cancer Cell Int. 2014. PMID: 25866477 Free PMC article.

Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene - PubMed (original) (raw)